healthcare
healthcare Articles
Turning Point Therapeutics shares dipped on Friday after the firm posted interim data for its midstage study in ROS1-positive non-small cell lung cancer patients.
Published:
Last Updated:
On Friday, May 31, the FDA is holding a hearing as a first step to developing review and approval procedures for products containing cannabidiol, the non-psychoactive ingredient in marijuana.
Published:
Last Updated:
Cara Therapeutics recently announced data from its late-stage trial in patients with chronic kidney disease. While there was a very positive reaction among investors, one analyst believes that this...
Published:
Last Updated:
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
Published:
Last Updated:
Cara shares jumped on Wednesday after the firm announced topline data from its late-stage trial in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus.
Published:
Last Updated:
Kezar Life Sciences shares were absolutely crushed on Tuesday after the firm revealed data from its midstage trial in patients with systemic lupus erythematosus.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Tonix Pharmaceuticals shares jumped on Thursday after the firm announced that it has in-licensed a Phase 2 asset, TNX-1300 for the treatment of cocaine intoxication.
Published:
Last Updated:
Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use its rapid-acting insulin and need a lower-cost option.
Published:
Last Updated:
Ocular Therapeutix shares took a beating on Tuesday after the firm announced late-stage results for patients with primary open-angle glaucoma or ocular hypertension. These results come from the Phase...
Published:
Last Updated:
BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema patients.
Published:
Last Updated:
Amyris shares jumped early on Monday on news that the firm had received its first payment from its cannabinoid partner.
Published:
Last Updated:
This is known as the world’s largest clinical cancer conference, and it always delivers new results on clinical trials and updated treatments in the field. Not to mention, this conference has the...
Published:
Last Updated: